Literature DB >> 9593908

Evidence that 5-HT3 receptors in the nucleus tractus solitarius and other brainstem areas modulate the vagal bradycardia evoked by activation of the von Bezold-Jarisch reflex in the anesthetized rat.

J G Pires1, S R Silva, A G Ramage, H A Futuro-Neto.   

Abstract

The effects of intracisternal (i.c.) application of the 5-HT3 receptor antagonist granisetron (0.016-0.16 microg kg-1) and the agonist phenylbiguanide (0.3-3 microg kg-1) on reflex bradycardia evoked by injection of phenylbiguanide (i.v.; 10 microg kg-1) were investigated in urethane anesthetized atenolol-pretreated rats. The effect of bilateral microinjection of granisetron (10 nmol per side, 100 nl) into the nucleus tractus solitarius (NTS) on the reflex was also investigated. Intracisternal administration of granisetron dose-dependently (0.016-0.16 microg kg-1) and significantly attenuated the reflex bradycardia whilst the highest dose given i.v. had no significant effect on the reflex bradycardia. Phenylbiguanide given i.c. only caused significant potentiation at the middle dose (1 microg kg-1), having no significant effects at the other doses. Neither granisetron nor phenylbiguanide given i.c. affected resting heart rate or blood pressure. Granisetron microinjected bilaterally into the NTS also significantly attenuated both reflex bradycardia and hypotension. It is concluded that excitation of cardiac vagal motoneurones evoked by cardiopulmonary afferents involves activation of 5-HT3 receptors located in the nucleus tractus solitarius and other brainstem areas. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593908     DOI: 10.1016/s0006-8993(98)00109-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.

Authors:  T Yoshikawa; N Yoshida; M Oka
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Glucose increases synaptic transmission from vagal afferent central nerve terminals via modulation of 5-HT3 receptors.

Authors:  Shuxia Wan; Kirsteen N Browning
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-18       Impact factor: 4.052

3.  The role of central 5-HT(1A) receptors in the control of B-fibre cardiac and bronchoconstrictor vagal preganglionic neurones in anaesthetized cats.

Authors:  Y Wang; A G Ramage
Journal:  J Physiol       Date:  2001-11-01       Impact factor: 5.182

4.  The role of central 5-HT3 receptors in vagal reflex inputs to neurones in the nucleus tractus solitarius of anaesthetized rats.

Authors:  Ross D Jeggo; Daniel O Kellett; Yun Wang; Andrew G Ramage; David Jordan
Journal:  J Physiol       Date:  2005-05-19       Impact factor: 5.182

5.  Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens.

Authors:  V M Pickel; J Chan
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

6.  Roles of arterial baroreceptor reflex during bezold-jarisch reflex.

Authors:  Koji Kashihara
Journal:  Curr Cardiol Rev       Date:  2009-11

7.  Dilatation induced by 5-HT in the middle meningeal artery of the anaesthetised cat.

Authors:  Geoffrey Andrew Lambert; Cathy Donaldson; Karen Lisa Hoskin; Peter Michael Boers; Alessandro Stefano Zagami
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-05-07       Impact factor: 3.000

8.  Afferent vagal nerve stimulation resets baroreflex neural arc and inhibits sympathetic nerve activity.

Authors:  Keita Saku; Takuya Kishi; Kazuo Sakamoto; Kazuya Hosokawa; Takafumi Sakamoto; Yoshinori Murayama; Takamori Kakino; Masataka Ikeda; Tomomi Ide; Kenji Sunagawa
Journal:  Physiol Rep       Date:  2014-09-04

Review 9.  Role of central vagal 5-HT3 receptors in gastrointestinal physiology and pathophysiology.

Authors:  Kirsteen N Browning
Journal:  Front Neurosci       Date:  2015-10-29       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.